Pharmacoeconomic review report Guselkumab (Tremfya) (Janssen Inc.)
Guselkumab (Tremfya) is a fully human immunoglobulin G1 lambda (IgG1a) monoclonal antibody that binds selectively to the interleukin 23 (IL-23) protein with high specificity and affinity. Levels of IL-23 are elevated in the skin of patients with plaque psoriasis and guselkumab exerts its clinical ef...
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa (ON) :
CADTH
2018.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820269606719 |
